...
首页> 外文期刊>Maturitas: International Journal for the Study of the Climacteric >Current treatment of dysfunctional uterine bleeding.
【24h】

Current treatment of dysfunctional uterine bleeding.

机译:目前治疗功能异常的子宫出血。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

OBJECTIVES: We performed a review of the treatment modalities for dysfunctional uterine bleeding. METHODS: Dysfunctional uterine bleeding can be treated medically or surgically. Medical treatment consists of anti-fibrinolytic tranexamic acid, non-steroidal anti-inflammatory drugs, the combined contraception pill, progestogen, danazol, or analogues of gonadotrophin releasing hormone. The levonorgestrel releasing intra uterine device is developed for contraception, but is also effective in the treatment of dysfunctional uterine bleeding. Surgical treatment includes endometrial ablation of the first and second-generation, and hysterectomy. This review contains current available evidence on the effectiveness of these therapies. RESULTS: Antifibrinolytic tranexamic acid is the most effective medical therapy to treat dysfunctional uterine bleeding. In general medical therapy is not as effective as endometrial resection in terms of patient satisfaction and health related quality of life. The levonorgestrel releasing intra uterine device is an effective treatment for dysfunctional uterine bleeding. No difference in quality of life was observed in patients treated with a levonorgestrel releasing intra uterine device as compared to hysterectomy. Ablation techniques of the first generation are effective and safe when used by trained surgeons, but have a learning curve. Ablation techniques of the second generation are effective, but long-term follow-up data are not available. Similarly, there are no large randomised controlled trials comparing the levonorgestrel releasing intra uterine device to first and second-generation ablation techniques. Hysterectomy, the traditional standard of care, has a relatively high complication rate, but it generates a high satisfaction rate and good health related quality of life scores. CONCLUSION: Since none of the treatments for dysfunctional bleeding is superior to one of the others, and since all treatments have their advantages and disadvantages, counselling of patients with dysfunctional bleeding should incorporate medical approach, levonorgestrel releasing IUD, endometrial ablation and hysterectomy.
机译:目的:我们对功能异常的子宫出血的治疗方式进行了回顾。方法:功能失调性子宫出血可通过药物或手术治疗。药物治疗包括抗纤溶的氨甲环酸,非甾体抗炎药,联合避孕药,孕激素,达那唑或促性腺激素释放激素类似物。左炔诺孕酮释放子宫内装置是为避孕而开发的,但也可有效治疗功能异常的子宫出血。手术治疗包括第一代和第二代子宫内膜切除术以及子宫切除术。这项审查包含有关这些疗法的有效性的现有证据。结果:抗纤溶性氨甲环酸是治疗功能失调性子宫出血的最有效药物。在患者满意度和与健康相关的生活质量方面,一般而言,药物治疗不如子宫内膜切除术有效。左炔诺孕酮释放子宫内装置是治疗功能异常子宫出血的有效方法。与子宫切除术相比,左炔诺孕酮释放子宫内装置治疗的患者的生活质量没有差异。当受过训练的外科医生使用时,第一代消融技术是有效且安全的,但具有学习曲线。第二代消融技术是有效的,但尚无长期随访数据。同样,也没有大型的随机对照试验将左炔诺孕酮释放子宫内装置与第一代和第二代消融技术进行比较。子宫切除术是传统的护理标准,其并发症发生率相对较高,但其满意度很高,并且与健康相关的生活质量得分较高。结论:由于功能障碍性出血的任何一种治疗方法都不优于其他方法,并且由于所有治疗方法都有其优缺点,因此对功能障碍性出血患者的咨询应采用医学方法,左炔诺孕酮释放宫内节育器,子宫内膜消融术和子宫切除术。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号